Clinical Trials Browser

Phase 1/2 × Recurrence × plerixafor × Clear all

NCT00903968 2020-06-02

Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma

Phase 1/2 Completed

58 enrolled 13 charts

Multiple Myeloma, Recurrence